Swedbank AB Boosts Stock Holdings in Globe Life Inc. $GL

Swedbank AB boosted its stake in shares of Globe Life Inc. (NYSE:GL) by 15.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,109,200 shares of the company’s stock after purchasing an additional 147,200 shares during the period. Swedbank AB’s holdings in Globe Life were worth $154,367,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in GL. DGS Capital Management LLC grew its stake in shares of Globe Life by 5.5% during the 1st quarter. DGS Capital Management LLC now owns 2,333 shares of the company’s stock valued at $325,000 after buying an additional 121 shares during the period. QRG Capital Management Inc. purchased a new position in shares of Globe Life in the 1st quarter worth $929,000. HB Wealth Management LLC boosted its holdings in Globe Life by 14.7% in the first quarter. HB Wealth Management LLC now owns 4,740 shares of the company’s stock valued at $660,000 after acquiring an additional 609 shares during the last quarter. Counterpoint Mutual Funds LLC acquired a new position in Globe Life in the first quarter valued at $294,000. Finally, Baer Investment Advisory LLC purchased a new stake in Globe Life during the first quarter valued at about $202,000. 81.61% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Globe Life

In other news, EVP Michael Clay Majors sold 34,000 shares of the company’s stock in a transaction dated Friday, April 24th. The shares were sold at an average price of $153.81, for a total value of $5,229,540.00. Following the sale, the executive vice president owned 53,518 shares in the company, valued at approximately $8,231,603.58. This represents a 38.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Frank M. Svoboda sold 20,000 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at $8,463,853.60. The trade was a 27.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 124,187 shares of company stock worth $19,529,414 over the last 90 days. Company insiders own 2.11% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on GL. Piper Sandler raised their price objective on Globe Life from $167.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, May 26th. Wells Fargo & Company boosted their target price on Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a report on Friday, April 10th. Morgan Stanley raised their price objective on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday. Keefe, Bruyette & Woods restated a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th. Finally, TD Cowen upped their target price on Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $178.89.

Globe Life Stock Up 1.4%

Shares of Globe Life stock traded up $2.53 on Tuesday, hitting $179.51. 109,765 shares of the company’s stock traded hands, compared to its average volume of 546,674. The stock has a market cap of $13.94 billion, a P/E ratio of 12.43 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The firm’s 50-day moving average is $161.66 and its 200 day moving average is $149.17. Globe Life Inc. has a 52-week low of $116.73 and a 52-week high of $182.32.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The company had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the business posted $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities analysts anticipate that Globe Life Inc. will post 15.64 earnings per share for the current year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.